<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
55700-129-60
</NDCCode>
<PackageDescription>
60 CAPSULE in 1 BOTTLE (55700-129-60)
</PackageDescription>
<NDC11Code>
55700-0129-60
</NDC11Code>
<ProductNDC>
55700-129
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Butalbital, Aspirin, And Caffeine
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Butalbital, Aspirin, And Caffeine
</NonProprietaryName>
<DosageFormName>
CAPSULE
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
19851011
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA086996
</ApplicationNumber>
<LabelerName>
Lake Erie Medical DBA Quality Care Products LLC
</LabelerName>
<SubstanceName>
BUTALBITAL; ASPIRIN; CAFFEINE
</SubstanceName>
<StrengthNumber>
50; 325; 40
</StrengthNumber>
<StrengthUnit>
mg/1; mg/1; mg/1
</StrengthUnit>
<Pharm_Classes>
Barbiturates [CS],Barbiturate [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE]
</Pharm_Classes>
<DEASchedule>
CIII
</DEASchedule>
<Status>
Deprecated
</Status>
<LastUpdate>
2019-10-18
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20191231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
19851011
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>